TLOG (TetraLogic Pharmaceuticals) Total Current Assets: $6.37 Mil (As of Sep. 2016)


What is TetraLogic Pharmaceuticals Total Current Assets?

TetraLogic Pharmaceuticals TLOG Total Current Assets is $6.37 Mil as of Sep. 2016.

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. TetraLogic Pharmaceuticals's total current assets for the quarter that ended in Sep. 2016 was $6.37 Mil.


TetraLogic Pharmaceuticals  (OTCPK:TLOG) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

TetraLogic Pharmaceuticals's Liquidation Value for the quarter that ended in Sep. 2016 is

Liquidation value
= Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=5.885-73.726+0.75 * 0+0.5 * 0
=-67.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TetraLogic Pharmaceuticals Total Current Assets Related Terms


TetraLogic Pharmaceuticals Total Current Assets Historical Data

* Premium members only.

The historical data trend for TetraLogic Pharmaceuticals's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TetraLogic Pharmaceuticals Total Current Assets Chart

TetraLogic Pharmaceuticals Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15
Total Current Assets
16.00 4.66 55.31 55.48 21.97

TetraLogic Pharmaceuticals Quarterly Data
Dec11 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16
Total Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.35 21.97 15.99 9.46 6.37

TetraLogic Pharmaceuticals Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

TetraLogic Pharmaceuticals's Total Current Assets for the fiscal year that ended in Dec. 2015 is calculated as

TetraLogic Pharmaceuticals's Total Current Assets for the quarter that ended in Sep. 2016 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Frequently Asked Questions Learn more about Total Current Assets →
What does a Total Current Assets of $6.37 Mil mean?
TetraLogic Pharmaceuticals (TLOG) has a Total Current Assets of $6.37 Mil as of Sep. 2016. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for TetraLogic Pharmaceuticals and its competitors.
Is TetraLogic Pharmaceuticals' Total Current Assets too high?
TetraLogic Pharmaceuticals' current Total Current Assets is $6.37 Mil.
How does TetraLogic Pharmaceuticals' Total Current Assets compare to ARGSQ and GTHR?
TetraLogic Pharmaceuticals' Total Current Assets of $6.37 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Current Assets for a Biotechnology company?
A good Total Current Assets depends on the Biotechnology industry context. However, Total Current Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Current Assets mean?
A high Total Current Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for TetraLogic Pharmaceuticals and its competitors. TetraLogic Pharmaceuticals's current Total Current Assets is $6.37 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TetraLogic Pharmaceuticals stock overvalued right now?
TetraLogic Pharmaceuticals (TLOG) has a current Total Current Assets of $6.37 Mil. The current Total Current Assets is $6.37 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Current Assets calculated?
Total Current Assets is calculated from a company's financial statements. For TetraLogic Pharmaceuticals (TLOG), the current Total Current Assets is $6.37 Mil as of Sep. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TetraLogic Pharmaceuticals Business Description

Address 343 Phoenixville Pike, Malvern, PA, USA, 19355
TetraLogic Pharmaceuticals Corp is a biopharmaceutical company. The company is engaged in developing novel small molecule therapeutics in oncology.